209 related articles for article (PubMed ID: 25439272)
1. Microbiome, innate immunity, and esophageal adenocarcinoma.
Baghdadi J; Chaudhary N; Pei Z; Yang L
Clin Lab Med; 2014 Dec; 34(4):721-32. PubMed ID: 25439272
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
Snider EJ; Freedberg DE; Abrams JA
Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
4. Microbiome in reflux disorders and esophageal adenocarcinoma.
Yang L; Chaudhary N; Baghdadi J; Pei Z
Cancer J; 2014; 20(3):207-10. PubMed ID: 24855009
[TBL] [Abstract][Full Text] [Related]
5. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma.
Zaidi AH; Kelly LA; Kreft RE; Barlek M; Omstead AN; Matsui D; Boyd NH; Gazarik KE; Heit MI; Nistico L; Kasi PM; Spirk TL; Byers B; Lloyd EJ; Landreneau RJ; Jobe BA
BMC Cancer; 2016 Feb; 16():52. PubMed ID: 26841926
[TBL] [Abstract][Full Text] [Related]
6. Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
Lopetuso LR; Severgnini M; Pecere S; Ponziani FR; Boskoski I; Larghi A; Quaranta G; Masucci L; Ianiro G; Camboni T; Gasbarrini A; Costamagna G; Consolandi C; Cammarota G
PLoS One; 2020; 15(5):e0231789. PubMed ID: 32369505
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
Yang L; Francois F; Pei Z
Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
[TBL] [Abstract][Full Text] [Related]
8. The Esophageal Microbiome in Health and Disease.
Corning B; Copland AP; Frye JW
Curr Gastroenterol Rep; 2018 Aug; 20(8):39. PubMed ID: 30069679
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for esophageal cancer: emphasis on infectious agents.
El-Zimaity H; Di Pilato V; Novella Ringressi M; Brcic I; Rajendra S; Langer R; Dislich B; Tripathi M; Guindi M; Riddell R
Ann N Y Acad Sci; 2018 Dec; 1434(1):319-332. PubMed ID: 29851130
[TBL] [Abstract][Full Text] [Related]
10. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
Neto AG; Whitaker A; Pei Z
Semin Oncol; 2016 Feb; 43(1):86-96. PubMed ID: 26970127
[TBL] [Abstract][Full Text] [Related]
11. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
12. The esophageal microbiota in health and disease.
Di Pilato V; Freschi G; Ringressi MN; Pallecchi L; Rossolini GM; Bechi P
Ann N Y Acad Sci; 2016 Oct; 1381(1):21-33. PubMed ID: 27415419
[TBL] [Abstract][Full Text] [Related]
13. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?
Blackett KL; Siddhi SS; Cleary S; Steed H; Miller MH; Macfarlane S; Macfarlane GT; Dillon JF
Aliment Pharmacol Ther; 2013 Jun; 37(11):1084-92. PubMed ID: 23600758
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome.
Ajayi TA; Cantrell S; Spann A; Garman KS
PLoS Pathog; 2018 Dec; 14(12):e1007384. PubMed ID: 30571768
[No Abstract] [Full Text] [Related]
15. The Role of the Microbiome in Gastrointestinal Cancer.
Wroblewski LE; Peek RM; Coburn LA
Gastroenterol Clin North Am; 2016 Sep; 45(3):543-56. PubMed ID: 27546848
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.
Gibson MK; Zaidi AH; Davison JM; Sanz AF; Hough B; Komatsu Y; Kosovec JE; Bhatt A; Malhotra U; Foxwell T; Rotoloni CL; Hoppo T; Jobe BA
Ann Surg; 2013 Jul; 258(1):82-8. PubMed ID: 23108119
[TBL] [Abstract][Full Text] [Related]
17. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
[TBL] [Abstract][Full Text] [Related]
18. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
Kountouras J; Chatzopoulos D; Zavos C
Med Hypotheses; 2007; 68(5):1174-5. PubMed ID: 17196756
[No Abstract] [Full Text] [Related]
19. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
20. Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.
Dan W; Peng L; Yan B; Li Z; Pan F
Front Microbiol; 2021; 12():791274. PubMed ID: 35126331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
